Interestingly, E715K that also demonstrated ligand-independent activity and robust potential to promote tumor formation in vivo, promoted enhanced kinase transactivation in ERBB4 homodimers and heterodimers, as suggested both by structural analyses of kinase dimerization interfaces as well as by an in vitro transactivation assay. This evidence concerns the gene ERBB4 and neoplasm.